Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Quick facts

Marketed products

• Blood samples for DOAC measurement · Diagnostics / Laboratory Medicine
  This is a laboratory testing service that measures direct oral anticoagulant (DOAC) concentrations in blood samples.
• exenatide (Byetta) · Diabetes
  Exenatide activates GLP-1 receptors on pancreatic beta cells to stimulate insulin secretion in response to elevated blood glucose.
• patients with sunitinib or pazopanib
• Povidone-Iodine 10%
• Randomisation to mepolizumab
• Randomisation to omalizumab · Immunology / Allergy
  Omalizumab is a monoclonal antibody that binds to circulating immunoglobulin E (IgE), preventing its interaction with high-affinity IgE receptors on mast cells and basophils.

Phase 3 pipeline

• Immunotherapeutic Agent · Immunology
  An immunotherapeutic agent that activates or modulates the immune system to enhance anti-tumor or anti-disease responses.
• O.M.T · Cardiovascular
  O.M.T is a medication used to treat atrial fibrillation.

Phase 1 pipeline

• Aerosoltherapy · Other
• biomarker · Other
• Theravac · Other

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Cliniques universitaires Saint-Luc- Université Catholique de Louvain portfolio CI brief
• Cliniques universitaires Saint-Luc- Université Catholique de Louvain pipeline updates RSS

Frequently asked questions about Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Related

• Blood samples for DOAC measurement · Diagnostics / Laboratory Medicine
• exenatide (Byetta) · Diabetes
• patients with sunitinib or pazopanib
• Povidone-Iodine 10%
• Randomisation to mepolizumab
• Sector hub: All tracked pharma companies